Detalhe da pesquisa
1.
Towards Equal Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy and Survival in Patients with Isolated Colorectal Peritoneal Metastases: A Nationwide Population-Based Study.
Ann Surg Oncol
; 31(6): 3758-3768, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38453767
2.
ASO Author Reflections: Addressing Hospital-Based Disparities in Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) and Survival in Patients with Isolated Colorectal Peritoneal Metastases.
Ann Surg Oncol
; 31(6): 3787-3788, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38498087
3.
ASO Visual Abstract: Towards Equal Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy and Survival in Patients with Isolated Colorectal Peritoneal Metastases-A Nationwide Population-Based Study.
Ann Surg Oncol
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38658412
4.
Population pharmacokinetics of intraperitoneal irinotecan and SN-38 in patients with peritoneal metastases from colorectal origin.
CPT Pharmacometrics Syst Pharmacol
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38634204
5.
Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases: protocol of the multicentre, open-label, phase II, INTERACT-II trial.
BMJ Open
; 14(1): e077667, 2024 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38238055
6.
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy with Intra-Operative Radiotherapy for Patients with Locally Advanced or Locally Recurrent Rectal Cancer and Peritoneal Metastases.
Cancers (Basel)
; 15(3)2023 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765814